Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $1.9 million.

  • Bolt Biotherapeutics' Shares Outstanding (Weighted Average) rose 36.01% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 36.01%. This contributed to the annual value of $38.2 million for FY2024, which is 98.37% up from last year.
  • Latest data reveals that Bolt Biotherapeutics reported Shares Outstanding (Weighted Average) of $1.9 million as of Q3 2025, which was up 36.01% from $1.9 million recorded in Q2 2025.
  • Bolt Biotherapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $38.3 million for Q1 2025, and its period low was $1.9 million during Q2 2024.
  • Over the past 5 years, Bolt Biotherapeutics' median Shares Outstanding (Weighted Average) value was $37.4 million (recorded in 2022), while the average stood at $29.0 million.
  • In the last 5 years, Bolt Biotherapeutics' Shares Outstanding (Weighted Average) soared by 11480727.59% in 2021 and then plummeted by 9494.97% in 2024.
  • Over the past 5 years, Bolt Biotherapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $33.2 million in 2021, then grew by 12.54% to $37.4 million in 2022, then grew by 1.21% to $37.8 million in 2023, then rose by 0.98% to $38.2 million in 2024, then tumbled by 94.97% to $1.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.9 million for Q3 2025, versus $1.9 million for Q2 2025 and $38.3 million for Q1 2025.